IP Library Granted Patent US 8,883,487
Granted Patent B2
US 8,883,487 · App. 12/308,307 · Granted Nov 11, 2014

Molecular diagnostics system and methods

Inventors: Gordon Bruce Collier (Fitzroy Harbour, CA); John Allister Wood (Sittsville, CA); Jason Andrew MacLeod (Ottawa, CA); William Charles Dicke (Aylmer, CA); Attila Csaba Nemeth (Ottawa, CA); Cary James Miller (Ottawa, CA)
Assignee: Abbott Point of Care Inc.
B01L3/502715C12Q1/6844C12Q1/686B01L3/502761B01L3/502769B01L7/52B01L2200/027B01L2200/0647B01L2200/10B01L2300/0816B01L2400/0421B01L2400/0487
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,883,487
App. No.
12/308,307
Filed
May 14, 2010
Granted
Nov 11, 2014
Kind
B2
Art Unit
1775
USPC
435/287.2
Abstract

The present invention relates to automated devices and methods for the extraction of nucleic acids from cells, the amplification of segments of nucleic acid and the detection of nucleic acids, all in a convenient and portable manner. The invention is particularly suited for use in point-of-care medical diagnostic testing.

Claims (44)

1. An integrated single-use device for performing a nucleic acid analysis, comprising:

a housing,

an entry port for accepting a sample suspected of containing a target nucleic acid,

a first chamber operably connected to the entry port and comprising:

a reagent for extracting the target nucleic acid,

magnet beads comprising a coating configured to bind the target nucleic acid, and

a wax configured to melt and form a contiguous wax layer in a region of egress of the first chamber;

a means for generating a magnetic field configured to draw the magnet beads through the contiguous wax layer;

a first conduit permitting passage of extracted nucleic acid from the region of egress of the first chamber into an amplification chamber, said housing containing an amplification reagent that is capable of incorporating a detectable label into an amplified nucleic acid target,

the amplification chamber having a heating means and a temperature sensing means for controlling amplification conditions,

the amplification chamber being operably linked to a second conduit containing a sensing region with an immobilized capture oligonucleotide,

a means for moving the amplified target to the sensing region to permit binding of said amplified target to said capture oligonucleotide, and

a holding chamber operably attached to said second conduit and containing a fluid configured to substantially displace uncaptured amplified target from the sensing region and permit sensing of said detectable label retained in said sensing region.

2. The device of claim 1 , wherein the label moiety is selected from the group consisting of fluorocein, dinitrophenol, biotin, cholesterol, digoxigenin and estrialdiol.

3. The device of claim 1 , wherein the sensing region is interrogated by an optical detector.

4. The device of claim 1 , wherein the sensing region is interrogated by an integrated optical detector.

5. The device of claim 1 , wherein the sensing region is interrogated by an integrated electrochemical detector.

6. The device of claim 1 , wherein amplification reagent is located in said first conduit.

7. The device of claim 1 , wherein amplification reagent is located in said amplification chamber.

8. The device of claim 1 , wherein amplification reagent is located in a holding chamber operably connected to said amplification chamber.

9. The device of claim 1 , wherein amplification reagent is located in a holding chamber operably connected to said first conduit.

10. The device of claim 1 , wherein said fluid is a wash fluid and contained in a sealed pouch within the holding chamber.

11. The device of claim 1 , wherein said means for moving the amplification target is pneumatic.

12. An integrated single-use device for performing a nucleic acid analysis, comprising:

a housing,

an entry port for accepting a sample suspected of containing a target nucleic acid,

a first chamber operably connected to the entry port and comprising:

a reagent for extracting the target nucleic acid onto magnetic beads that are located in the first chamber, and

a wax configured to melt and form a substantially contiguous wax layer that covers an egress region of the first chamber into a first conduit,

wherein the magnetic beads that are associated with the extracted target nucleic acid are configured to pass through the wax layer into the first conduit by means of an applied magnetic field,

the first conduit permitting passage of the extracted target nucleic acid and the magnetic beads into an amplification chamber, said housing containing an amplification reagent that is capable of incorporating a detectable label into an amplified nucleic acid target,

the amplification chamber having a heating means and a temperature sensing means for controlling amplification conditions,

the amplification chamber being operably linked to a second conduit containing a sensing region with an immobilized capture oligonucleotide,

said housing containing a means for moving the amplified target to the sensing region to permit binding of said amplified target to said capture oligonucleotide, and

a holding chamber operably attached to said second conduit and containing a fluid configured to substantially displace uncaptured amplified target from the sensing region and permit optical sensing of the detectable label retained in the sensing region.

13. The device of claim 12 , wherein the detectable label is selected from the group consisting of fluorocein, dinitrophenol, biotin, cholesterol, digoxigenin and estrialdiol.

14. The device of claim 12 , wherein the sensing region is interrogated by an optical detector.

15. The device of claim 12 ; wherein the sensing region is interrogated by an integrated optical detector.

16. The device of claim 12 , wherein amplification reagent is located in said first conduit.

17. The device of claim 12 , wherein amplification reagent is located in said amplification chamber.

18. The device of claim 12 , wherein amplification reagent is located in a holding chamber operably connected to said amplification chamber.

19. The device of claim 12 , wherein amplification reagent is located in a holding chamber operably connected to said first conduit.

20. The device of claim 12 , wherein said fluid is a wash fluid and contained in a sealed pouch within the holding chamber.

21. The device of claim 12 , wherein said means for moving the amplification target is pneumatic.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 26, 2010
From: COLLIER, GORDON BRUCE; WOOD, JOHN ALLISTER; MACLEOD, JASON ANDREW; DICKE, WILLIAM CHARLES; NEMETH, ATTILA CSABA; MILLER, CARY JAMES
To: ABBOTT POINT OF CARE INC.
Reel/Frame 023999/0731 →
CHANGE OF NAME Recorded Mar 19, 2009
From: I-STAT CORPORATION
To: ABBOTT POINT OF CARE INC.
Reel/Frame 022416/0268 →
Continuity (2)
Provisional Application 60638177 · Dec 23, 2004
Related Publication 20100291666A1 · Nov 18, 2010